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SUMMARY
A total of2431 fine needleaspiratesofsymptomaticbreastlumps wasperformedon2096patients
over the last three years at the weekly head, neck and breast clinic at the Belfast City Hospital
Trust. Diagnostic accuracy was achieved within the recommended standards although the
"insufficient" rate was high at31.8%. False negative and positive rates were low and the positive
predictive value for malignancy was 99%. Excision biopsy for benign breast disease had
decreased by almost a third during this period. Fine needle aspiration cytology is a highly
accurate and cost- effective technique for the investigation of symptomatic breast lumps and
results in significant savings.
INTRODUCTION
Fine needle aspiration cytology (FNAC) is now a
well established investigative technique for the
pre-operative diagnosis of breast lumps. It has
gained wide acceptance due to its simplicity,
highaccuracy, tolerabilityandcosteffectiveness.
Complications following the procedure are rare.
There has been a weekly FNAC service for the
head, neck and breast clinic at the Belfast City
Hospital since 1990. This audit covers the last
three years. The aim is to assess our diagnostic
accuracy and to determine if we have achieved
the standards set by the National Health Service
Breast Screening Programme (NHSBSP), which
also apply to symptomatic cases.'
PATIENTS AND METHODS
Since August 1990, Histo/Cytopathology
Consultants and trainees have been involved in
the taking and interpretation of fine needle
aspirates of symptomatic breast lumps. New
patients and review cases are first seen by a
consultant surgeon and his team at the weekly
head, neck and breast clinic. Patients are first
assessed clinically and referred to the aspiration
team if appropriate. Aspirates are performed
freehandwitha23-gaugeneedleand20mlsyringe
mounted on a Cameco handle. The aspirates are
air-dried and stained with Speedy-Diff (Clin-
tech). The slides areassessedfirstlyforadequacy
of material, and in some cases an immediate
provisional diagnosis is given to the surgeon.
Written reports on specimens are issued the next
day and are grouped into five categories:
1. Insufficient or inadequate - if less than five
groups of epithelium are obtained.
2. Benign - including cysts, inflammatory
conditions and benign tumours.
3. Atypia - probably benign.
4. Suspicious of malignancy.
5. Unequivocally malignant.
RESULTS
Overthe last three years 2096 patients were seen
yielding 2431 aspirates, including bilateral and
multiple lumps in some patients. Table I shows
the diagnostic categories, biopsy rates and the
ratio of malignant to benign surgical excisions
foreachyear. Thestatisticalanalysisoftheoverall
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results is shown in Table II with suggested
minimum values from the NHSBSP in
parentheses. 341 patients underwent excision
biopsy or definitive surgery. Correlation of the
histological diagnosis and cytological results is
shown in Table III. Forty-one patients with
advanced carcinoma were not operated upon and
were managed conservatively.
TABLE I
1993-4 1994-5 1995-6
Year 1 2 3
No. of patients aspirated 653 777 666
Total No. of aspirates 753 922 756
Category 1 235 (31.2%) 315 (34.2%) 224 (29.6%)
2 454 (60.3%) 530 (57.5%) 466 (58.9%)
3 17 (2.2%) 30 (30.2%) 15 (1.9%)
4 11 (1.4%) 15 (1.6%) 13 (1.7%)
5 36 (4.8%) 32 (3.5%) 38 (5%)
Biopsy - Malignant (M) 31 33 44
- Benign (B) 92 78 63
- Total 123 111 107
Excision Rate 16.2% 12% 14.15%
M:B Ratio 1:2.9 1:2.4 1:1.3
TABLE II
Overall results ofthe three year audit with suggested minimum values in parentheses
Total number of patients seen 2096
Total number of aspirates performed 2431
Insufficient rate 31.8% (<25%)
Absolute sensitivity 70.5% (>60%)
Complete sensitivity - 90.8% (>80%)
Full specificity - 63.7% (>60%)
PPV (C5 diagnosis) - 99.1% (>95%)
False negative rate (excluding Cl) - 3.95% (<5%)
False positive rate - 0.7% (<1%)
(0%) *
* Malignant cytology not proven on biopsy
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TABLE III
Category No. of No. Biopsy Result Histological
Aspirates Biopsied Diagnosis
(%) (%) Benign (%) Malignant (%)
1 774 (31.8) 77 (9.9) 69 (89) 8 (11) 4ILC,3IDC,1TLC
2 1450 (60) 123 (8.5) 117 (95) 6 (5) 2 IDC,X 1 -TLC,
MPHY, ICC, DCIS
3 62 (2.5) 47 (76) 42 (89) 5 (11) 3 IDC (R)
2 ILC (R)
4 39 (1.6) 29 (74) 4 (14) 25 (86) 2FCD IFA 1 ADH
5 106 (4.4) 65 (61) 1 (0.7) 64 (98) 1 FA
IDC - Infiltrating ductal carcinoma DCIS - Ductal carcinoma in situ
ILC - Infiltrating lobular carcinoma R - Recurrence
TLC - Tubulo-lobular carcinoma FCD - Fibrocystic disease
MPHY - Malignant phyllodes tumour ADH - Atypical ductal hyperplasia
ICC - Intracystic carcinoma FA - Fibroadenoma
FALSE NEGATIVES AND POSITIVES
There was a total of 14 false negative cases
including insufficient aspirates. These were due
to sampling and interpretation error in equal
proportions. Importantly, 13 ofthe 14 cases had
eithersuspicious mammographic findingsorwere
clinically worrying although one was thought to
be benign both radiologically and clinically. In
category 3, atypical changes in five cases were
thought possibly to be related to post-surgical
irradiation but these proved to be recurrent
tumours in subsequent biopsies.
Four cases were regarded as suspicious of
malignancy (category 4). However biopsy
revealed one case of atypical ductal hyperplasia
while the remainder were of florid fibrocystic
breast disease. One case was diagnosed as
unequivocally malignant on cytology (category
5)butlumpectomy andaxillary sampling showed
no tumour. Review of the aspirate confirmed
malignant cells and the patient was referred for
adjuvant radiotherapy.
DISCUSSION
Fine needle aspiration cytology has largely
supersededtheuse of"Trucut" needlebiopsy and
frozen section examination in the investigation
of symptomatic breast lumps. With the use of
FNAC in our centre the number of biopsies of
breast disease proven to be benign has fallen
gradually from a ratio of almost three benign
excisions to one malignant to near parity. Some
women with symptomatic lumps however still
opt for surgical intervention despite a benign
cytologyreport. Conversely, elderlywomenwith
advanced cancers could be spared unnecessary
biopsy following confirmation of the diagnosis
by FNAC.
The audit shows our "insufficient" rate of31.8%
is higherthan the recommended value. However,
audit findings from various centres2'3 report an
insufficient rateranging from 20% to46.8%. Itis
dependent on patient selection and the number
andexperienceofaspirators. Ill-definedclinically
benign iumps are usually acellular and are not
suitable forFNAC. In somecentres,4 cases oflow
cellularity which remain inadequate on re-
aspiration are not reported as inadequate. Many
studies5'7haveshownthatbestresultsareobtained
in centres with a small selected group of well
motivated aspirators be they pathologists or
surgeons although controversy remains as to
which ofthe two should best take the aspirate. In
ouropinion, wheretimeandresourcespermit, the
pathologist is better suited to perform the
aspiration. Important information canbe gleaned
while needling a tumour such as its consistency,
presenceofgrittinessandtendencytobleedwhich
may help to correlate the cytological and clinical
findings. With experience, an aspirator will
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develop a "feel" for obtaining a representative
sample.
Elevenpercentofourinsufficientcasesprovedto
bemalignantonbiopsyfollow-up. Thiscompares
relativelywellwithotherreports3butanincidence
ofcarcinomain insufficient samples ofas high as
32% has been reported.8 The low specificity in
our series is partly due to the high insufficient
rate and partly to the low biopsy rate of benign
cases. Incertaincentresthebiopsyrateforbenign
cases was as high as 37%.4
False negative cases were due either to sampling
orinterpretationerror. Samplingerrorwasusually
encounteredwith smalldeep seatedtumours orin
encysted carcinomas while the under diagnosis
oflow grade tumours such as infiltrating lobular,
tubular, tubulolobular and Grade I infiltrating
duct carcinomas is a well recognised pitfall
especially in sparsely cellular aspirates.9 Four of
29 cases (13.7%) were regarded as suspicious of
malignancy; they were subsequently proven
benign on histology. Matthews et al10 reported
18.4% of the category 4 cases were as wrongly
diagnosed. Certain benign lesions, particularly
atypical hyperplasia, some florid fibrocystic
disease and even fibroadenomas may have
disconcerting cytological features. The positive
predictive value for carcinoma however remains
very high and to reduce both the false-negative
andfalse-positiveratestoaminimumacombined
(triple) approach with clinical examination and
radiological assessment is imperative. A "one-
stop" breast clinic with facilities for immediate
FNAC reporting offers the most efficient
managementofpatients withsymptomatic breast
lumps and results in significant savings.
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